A detailed history of Toroso Investments, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Toroso Investments, LLC holds 5,397 shares of PCVX stock, worth $610,292. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,397
Previous 5,928 8.96%
Holding current value
$610,292
Previous $404,000 0.74%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$60.06 - $78.77 $31,891 - $41,826
-531 Reduced 8.96%
5,397 $407,000
Q1 2024

May 15, 2024

BUY
$59.79 - $81.05 $354,435 - $480,464
5,928 New
5,928 $404,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $6.71B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.